A novel AQP9 inhibitor, RG100204, was found to attenuate cardiac dysfunction as well as renal dysfunction and hepatocellular injury in a cecal ligation and puncture (CLP) model of sepsis. This evidence concerns the gene AQP9 and Sepsis.